bendamustine hydrochloride

{
  "id": "MLC-T-ONC-000981",
  "term": "bendamustine hydrochloride",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Bendamustine hydrochloride damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called Belrapzo, Bendeka, and Treanda.",
    "The hydrochloride salt of bendamustine, a bifunctional mechlorethamine derivative with alkylator and antimetabolite activities. Bendamustine possesses three active moieties: an alkylating group; a benzimidazole ring, which may act as a purine analogue; and a butyric acid side chain. Although its exact mechanism of action is unknown, this agent appears to act primarily as an alkylator. Bendamustine metabolites alkylate and crosslink macromolecules, resulting in DNA, RNA and protein synthesis inhibition, and, subsequently, apoptosis. Bendamustine may differ from other alkylators in that it may be more potent in activating p53-dependent stress pathways and inducing apoptosis; it may induce mitotic catastrophe; and it may activate a base excision DNA repair pathway rather than an alkyltransferase DNA repair mechanism. Accordingly, this agent may be more efficacious and less susceptible to drug resistance than other alkylators."
  ],
  "synonyms": [
    "Belrapzo",
    "Bendeka",
    "Treanda",
    "cytostasan hydrochloride",
    "bendamustin hydrochloride",
    "CEP-18083"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/bendamustine-hydrochloride/"
}